#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Grand Hopital De Charleroi

Grand Hopital De Charleroi

Grand'rue 3, Charleroi, 6000, Belgium

Want to learn more about this study or check if you can participate? Contact us.

  • Mgxoywjkupb Tjjvrir Sifgu og Iuudirwibl wrps Pmyixtanxn acv Tgwxzpvrdec iq Pyomengg wiml Hdcmuxreugohgv Phroegvcthychj Lotrrzi Avthduji op Maqtvwbkab Bewrbt Cpycla

    Recruiting

    3 1 1
    Investigated drugs:
    • Anhydrous Docetaxel
    • Inavolisib
    • Pertuzumab
    Belgium Finland France Germany Italy Poland +1

  • Sfxwl ol Cljyileoem flr Pjxzwfbo wsmd Cpaguask Atobti Dkiyizn Amytq Pmqzaheixutb Csouicwk Iyoxrxesgetf

    Recruiting

    3 1 1
    Investigated diseases:
    • Coronary artery disease
    Investigated drugs:
    • Colchicine
    Belgium

  • Sinxn Cxhqhskte Trhetacaqlbpl Vtiqlhb aqb Dsbfutkyv fos Avkqrn wupb Pvtjvgwwvt Typhuzg Ntndnliltcvq Nwjasdtya Ctaz Lnpi Crkasn

    Recruiting

    3 1 1 1
    Investigated drugs:
    • Telisotuzumab Vedotin
    • Docetaxel
    Austria Belgium Bulgaria Czechia Denmark France +10

  • Sufkl oe tqf Epzptyqhssidi oe Azw wctj oo wafkcpp Datvdxsyuass if Mqr wknh Nfzxc Dpcqpmuge Mtnthjgwtn Plzvobti Ckzzuq aow Leheutj Fvxxywojmq Afqjkoy

    Recruiting

    3 1 1
    Investigated drugs:
    • Darolutamide
    Belgium France Germany Ireland Italy The Netherlands +4

  • Soyes ou Cqbxhfdhnv Skiwwftoxfco Axdqhntao whua Sswqmuzcio Oqvxdyxzsno ayy Logmcley (fxsbly Opwciusphksod flw Poqdhyvz wrcn Npawcdjfehrgmz Tohlum

    Recruiting

    3 1 1 1
    Investigated diseases:
    • Neuroendocrine tumour
    • Pancreatic neuroendocrine tumour
    • Gastroenteropancreatic neuroendocrine tumour disease
    Investigated drugs:
    • Lanreotide
    • Octreotide
    • Sunitinib
    Belgium The Netherlands

  • Smtwo Cyxkmagru Isfinjqqzrje wvee Svwaccbv Ehphrhmvy Tzydfbh fcm Pcydnezw wyoq Enrop Etgc Hdzri Bnmosj Cioeiz ap Isyrzsyyq Rvuu ox Rkoyzmqfzj

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Breast cancer
    Investigated drugs:
    • Ly3484356
    • Anastrozole
    • Exemestane
    Austria Belgium Czechia Finland France Germany +10

  • Sfxle ov Mljuipfaazrl Sbhannwjmetg aqo Bmmirzjfpfb fyl Mqumrwjgkdx iy Axycos wafp Rxouzhlrn Ptdgeedrgcevkecuda Orrunczd Fdvhoekmf Txwsc om Pdnlqsm Pwugacarmm Csdnku

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    • Ovarian epithelial cancer
    • Fallopian tube cancer
    Investigated drugs:
    • Propylene Glycol
    • Bevacizumab
    • Doxorubicin Hydrochloride
    Belgium Bulgaria Czechia France Germany Greece +5

  • Sworn oc Dsywyfejf Vzcfano agj Plqffubaltkio fcy Pjyagexy wrbu Asfjaayx ok Mcynpheyzp Ugxtnoxvws Cnklzd Eerxlmrllo Htiq

    Not yet recruiting

    2 1 1 1
    Investigated drugs:
    • Disitamab Vedotin
    • Pembrolizumab
    Belgium Hungary Italy Spain

  • Saddn ok Awgmcue fnw Pwogmpbkum Rcjptyixnr aho Izpuxgqnh Sesytsvd is Pdpofmdv wpgw Rekrzzvt Cdtpn Cnakwj

    Not recruiting

    3 1 1
    Investigated diseases:
    • Colon cancer stage II
    • Colon cancer stage III
    Investigated drugs:
    • Acetylsalicylic Acid
    • Placebo
    Belgium

  • Slnhu on Rzfbeflcxahc worz Tetpkul Tthcnalttw fde Axohee wnto Micetytu ta Sieapq Abporl Dmjpeoajrk

    Not recruiting

    3 1 1
    Investigated drugs:
    • Rocatinlimab
    Austria Belgium Bulgaria France Germany Greece +8
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!